Hyperbaric Oxygen Therapy

A Pilot Study to Determine the Safety and Efficacy of Incorporating Hyperbaric Oxygen Therapy Into RIC Fludarabine and Melphalan and Allogeneic Hematopoietic Stem/Progenitor Transplantation

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
24 patients (estimated)
Sponsors
University of Rochester Medical Center Wilmot Cancer Center
Tags
Allogeneic Stem Cell Transplant, Chemotherapy
Trial Type
Treatment
Last Update
1 month ago
SparkCures ID
1650
NCT Identifier
NCT03964506

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.